Cryptogenic organizing pneumonia causes: Difference between revisions
(/* Infectious agents{{cite journal| author=Cordier JF| title=Organising pneumonia. | journal=Thorax | year= 2000 | volume= 55 | issue= 4 | pages= 318-28 | pmid=10722773 | doi= | pmc=PMC1745738 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?...) |
|||
Line 33: | Line 33: | ||
*[[Streptococcus pneumoniae]]<ref name="pmid10722773">{{cite journal| author=Cordier JF| title=Organising pneumonia. | journal=Thorax | year= 2000 | volume= 55 | issue= 4 | pages= 318-28 | pmid=10722773 | doi= | pmc=PMC1745738 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10722773 }} </ref> | *[[Streptococcus pneumoniae]]<ref name="pmid10722773">{{cite journal| author=Cordier JF| title=Organising pneumonia. | journal=Thorax | year= 2000 | volume= 55 | issue= 4 | pages= 318-28 | pmid=10722773 | doi= | pmc=PMC1745738 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10722773 }} </ref> | ||
===Drugs | ===Drugs=== | ||
*[[Acebutolol]] | *[[Acebutolol]] | ||
*[[Amiodarone]] | *[[Amiodarone]] | ||
Line 106: | Line 105: | ||
*[[Topotecan]] | *[[Topotecan]] | ||
*[[Trastuzumab]] | *[[Trastuzumab]] | ||
*[[Tryptophan]] | *[[Tryptophan]]<ref name="pneumotox">Organizing pneumonia (OP/BOOP). Pneumotox.com, The Drug-Induced Respiratory Disease Website. Available at http://www.pneumotox.com/pattern/view/5/I.d/organizing-pneumonia-op-boop/. Accessed on February 1, 2016.</ref> | ||
</ | |||
===Inflammatory diseases=== | ===Inflammatory diseases=== |
Revision as of 22:48, 28 February 2018
Cryptogenic Organizing Pneumonia Microchapters |
Differentiating Cryptogenic organizing pneumonia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryptogenic organizing pneumonia causes On the Web |
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia causes |
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
Risk calculators and risk factors for Cryptogenic organizing pneumonia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2] Serge Korjian M.D.
Overview
By definition, cryptogenic organizing pneumonia has no identifiable etiology; however, organizing pneumonia secondary to a known etiology is clinically identical to COP. Some of the causes of organizing pneumonia include infectious agents, drugs, inflammatory diseases, and toxic exposures.
Causes
- By definition, cryptogenic organizing pneumonia has no identifiable etiology.
- However, organizing pneumonia secondary to a known etiology is clinically identical to COP.
- Some of the causes of organizing pneumonia include infectious agents, drugs, inflammatory diseases, and toxic exposures.
- These causes need to be ruled out for a diagnosis of COP to be made.
Infectious agents
- Chlamydia pneumoniae
- Coxiella burnetii
- Cryptococcus neoformans
- Herpes virus
- Human immunodeficiency virus
- Influenza virus
- Legionella pneumophila
- Mycoplasma pneumoniae
- Nocardia asteroides
- Parainfluenza virus
- Penicillium janthinellum
- Plasmodium vivax
- Pneumocystis carinii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Streptococcus group B
- Streptococcus pneumoniae[1]
Drugs
- Acebutolol
- Amiodarone
- Amphotericin B
- Atorvastatin
- Azacytidine
- Azathioprine
- Betaxolol
- Bleomycin
- Bortezomib
- Bucillamine
- Busulfan
- Carbamazepine
- Cephalexin
- Chlorambucil
- Cladribine
- Clomipramine
- Cocaine
- Crizotinib
- Cyclophosphamide
- Cytarabine
- Daptomycin
- Doxorubicin
- Dronedarone
- Drug-eluting stents
- Ergot alkaloids
- Erlotinib
- Etanercept
- Everolimus
- Fludarabine
- Fosinopril
- Gold (chrysotherapy)
- Heroin (injected)
- Hexamethonium
- Hydralazine
- Hydroxyurea
- Imatinib
- Imipramine
- Infliximab
- Interferon-alpha/beta
- Ipilimumab
- Leflunomide
- Lenalidomide
- Loxoprofen
- Mecamylamine
- Mesalazine (5-aminosalicylate)
- Methotrexate
- Minocycline
- Nilutamide
- Nitrofurantoin
- Oxaliplatin
- Penicillamine
- Phenytoin (diphenylhydantoin)
- Pravastatin
- Propylthiouracil (PTU)
- Quinine
- Risedronate
- Rituximab
- Sertraline
- Simvastatin
- Sirolimus
- Sotalol
- Sulfasalazine
- Sulindac
- Tacrolimus
- Temozolomide
- Thalidomide
- Ticlopidine
- Timolol
- Tocilizumab
- Topotecan
- Trastuzumab
- Tryptophan[2]
Inflammatory diseases
Toxic exposures[2]
References
- ↑ Cordier JF (2000). "Organising pneumonia". Thorax. 55 (4): 318–28. PMC 1745738. PMID 10722773.
- ↑ 2.0 2.1 Organizing pneumonia (OP/BOOP). Pneumotox.com, The Drug-Induced Respiratory Disease Website. Available at http://www.pneumotox.com/pattern/view/5/I.d/organizing-pneumonia-op-boop/. Accessed on February 1, 2016.